$BBIO BridgeBio Pharma, Inc. Insider Trading
Get free email notifications about insider trading in BridgeBio Pharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BridgeBio Pharma, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in BridgeBio Pharma, Inc. for free.
CIK Number: 0001743881
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: BBIO
Company Address: 421 KIPLING STREET PALO ALTO 94301
Former name: BridgeBio Pharma LLC, date of change: 2018-06-18
BridgeBio Pharma, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 22 2021 | BBIO | BridgeBio Pharma, ... | HOMCY CHARLES J | Director | Option Exercise | A | 62.63 | 38,895 | 2,435,994 | 38,895 | |
Jun 22 2021 | BBIO | BridgeBio Pharma, ... | DANIELS RONALD J | Director | Option Exercise | A | 62.63 | 38,895 | 2,435,994 | 38,895 | |
Jun 22 2021 | BBIO | BridgeBio Pharma, ... | SAUNDERS BRENT L | Director | Option Exercise | A | 62.63 | 38,895 | 2,435,994 | 38,895 | |
Jun 22 2021 | BBIO | BridgeBio Pharma, ... | AGUIAR ERIC | Director | Option Exercise | A | 62.63 | 38,895 | 2,435,994 | 38,895 | |
Feb 18 2021 | BBIO | BridgeBio Pharma, ... | STEPHENSON BRIAN C | See Remarks | Option Exercise | M | 0.00 | 1,710 | 0 | 22,227 | |
Feb 18 2021 | BBIO | BridgeBio Pharma, ... | STEPHENSON BRIAN C | See Remarks | Buy | P | 62.50 | 8,000 | 500,000 | 300,043 | 292 K to 300 K (+2.74 %) |
Feb 18 2021 | BBIO | BridgeBio Pharma, ... | STEPHENSON BRIAN C | See Remarks | Payment of Exercise | F | 64.98 | 592 | 38,468 | 292,043 | 292.6 K to 292 K (-0.20 %) |
Feb 18 2021 | BBIO | BridgeBio Pharma, ... | STEPHENSON BRIAN C | See Remarks | Buy | M | 0.00 | 1,710 | 0 | 292,635 | 290.9 K to 292.6 K (+0.59 %) |
Feb 18 2021 | BBIO | BridgeBio Pharma, ... | Kumar Neil | CEO and President | Option Exercise | M | 0.00 | 5,129 | 0 | 66,682 | |
Feb 18 2021 | BBIO | BridgeBio Pharma, ... | Kumar Neil | CEO and President | Payment of Exercise | F | 62.50 | 16,000 | 1,000,000 | 4,711,425 | 4.7 M to 4.7 M (+0.34 %) |
Feb 18 2021 | BBIO | BridgeBio Pharma, ... | Kumar Neil | CEO and President | Payment of Exercise | F | 64.98 | 2,139 | 138,992 | 4,695,425 | 4.7 M to 4.7 M (-0.05 %) |
Feb 18 2021 | BBIO | BridgeBio Pharma, ... | Kumar Neil | CEO and President | Buy | M | 0.00 | 5,129 | 0 | 4,697,564 | 4.7 M to 4.7 M (+0.11 %) |
Feb 17 2021 | BBIO | BridgeBio Pharma, ... | KKR Genetic Disorder L.P. | Sell | S | 60.47 | 3,450,000 | 208,617,360 | 31,060,971 | 34.5 M to 31.1 M (-10.00 %) | |
Feb 12 2021 | BBIO | BridgeBio Pharma, ... | STEPHENSON BRIAN C | See Remarks | Option Exercise | A | 0.00 | 12,449 | 0 | 12,449 | |
Feb 12 2021 | BBIO | BridgeBio Pharma, ... | STEPHENSON BRIAN C | See Remarks | Option Exercise | A | 68.87 | 73,440 | 5,057,813 | 73,440 |